Real-life effectiveness of Singulair® (Montelukast) in 506 children with mild to moderate asthma

Israel Medical Association Journal

Volumn 10, Issue 4, 2008, Pages 287-291

  Amirav, Israel ^a,b  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Asthma; Inflammation; Montelukast; Real life study

Indexed keywords

BUDESONIDE; CORTICOSTEROID; MONTELUKAST; SALBUTAMOL;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BEDTIME DOSAGE; CHILD; CHILD CARE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG UTILIZATION; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PARENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEDIATRICIAN; SATISFACTION; SLEEP DEPRIVATION; SYMPTOM; WHEEZING;

ACETATES; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; PATIENT SATISFACTION; QUINOLINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 43249102676     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma: United States, 1980-1999. MMWR CDC Surveill Summ 2002;51:1-13
2. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9.
3. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6, to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study group. JAMA 1998;279:1181-6.
4. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:E48.
5. Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos. P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma the MOSAIC study. Pediatrics 2005 116:360-9.
6. Bombardier C, Maetzel,A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? Ann Rheum Dis 1999;58(Suppl 1):182-5.
7. Yawn BP, Fryer GE, Lanier D. Asthma severity: the patient's perspective. J Asthma 2004;41:623-30.
8. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE; for the TENOR Study Group. Severity assessment in asthma: An evolving concept. J Allergy Clin Immunol 2005;116:990-5.
9. Robertson CF, Rubinfeld AR, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992;13:95-100.
10. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98(6 Pt 1):1051-7.
11. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-52.
12. Maspero JF, Duenas-Meza E, Volovitz B, et al. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001;17:96-104.